The Coffee Break: With James Grinias
By James Strachan
April 30, 2026
Jim Grinias shares the ideas and debates shaping conference conversations – from AI to interdisciplinary science
7 min read
False
By James Strachan
April 30, 2026
Jim Grinias shares the ideas and debates shaping conference conversations – from AI to interdisciplinary science
7 min read
By James Strachan
April 8, 2026
Microdroplets formed during electrospray ionization may trigger chemical reactions that help explain a substantial portion of the “dark metabolome” – though some researchers question their relevance under typical metabolomics conditions
7 min read
March 23, 2026
Thomas Letzel reflects on the evolution of non-target screening and why interdisciplinary insights are key to its future
6 min read
March 11, 2026
Large-cohort CSF proteomics from the Mann Lab identifies a 22-protein panel distinguishing MS from related diseases
2 min read
By James Strachan
March 11, 2026
Silvana Andreescu on the urgent need for low-cost, field-deployable PFAS sensors
7 min read
By James Strachan
March 4, 2026
David Megson calls for joined-up thinking, smarter analysis, and stronger partnerships between academia, industry, and government
9 min read
February 23, 2026
Carrie McDonough explores how PFAS move, bind, and transform within us – redefining what exposure really means
13 min read
By Amanda M. Guiraldelli, Piotr Alvarez, Koen Sandra
January 26, 2026
The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.
12 min read
By Alexander Makarov, Bashar Amer, Susan S. Bird, ..et al.
December 15, 2025
Advanced software tools and self-correcting instruments could soon put the dark metabolome debate to bed, argue Alexander Makarov and the Thermo Fisher Scientific team
4 min read
By Henry Thomas
December 11, 2025
By fusing multi-omics data with AI, Sapient Founder Mo Jain believes researchers will close the gap between molecular measurement and clinical meaning
10 min read
False
False
False